Atlas Trials

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)

Clinical trial NCT02104245 · COMPLETED

Trial details

NCT number
NCT02104245
Sponsor
Aradigm Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non Cystic Fibrosis Bronchiectasis
Start date
2014-05-28
Primary completion
2016-08-11
Enrollment
304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.